Get a glimpse into our company and investor data—powered by the PitchBook Platform
American BriVision Holding
$6.50SHARE PRICE(As of Tuesday Closing)
American BriVision Holding Corp is a clinical stage bio pharmaceutical company. Its focus is on enhancing the already available pharmaceutical products for cancer and other diseases and commercialize the same. The company is into the research and development of five compounds licensed by a Taiwanese company named BioLite Inc.